'Cancer' Label for Low-Risk Prostate Lesions? Patients Split
Medscape,
For more than a decade, physicians have debated whether a type of low-risk prostate cancer ought to be called something other…
For more than a decade, physicians have debated whether a type of low-risk prostate cancer ought to be called something other…
Der urologische Onkologe Scott Eggener, stellvertretender Vorsitzender der Urologie an der University of Chicago Medicine, warf…
Special Reports > A Patient's Journey Physicians must consider patient perspectives on the Gleason 6 debate by Contributing…